n(g)-iminoethylornithine has been researched along with morphine in 5 studies
| Studies (n(g)-iminoethylornithine) | Trials (n(g)-iminoethylornithine) | Recent Studies (post-2010) (n(g)-iminoethylornithine) | Studies (morphine) | Trials (morphine) | Recent Studies (post-2010) (morphine) |
|---|---|---|---|---|---|
| 171 | 1 | 36 | 44,270 | 5,200 | 8,695 |
| Protein | Taxonomy | n(g)-iminoethylornithine (IC50) | morphine (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.2939 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.2278 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 0.0828 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0385 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0545 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.122 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.1199 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.9308 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.655 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.3305 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.202 | |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.25 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duarte, ID; Ferreira, SH | 1 |
| Duarte, ID; Ferreira, SH; Lorenzetti, BB | 1 |
| Kimes, AS; London, ED; Vaupel, DB | 1 |
| Adler, MW; Benamar, K; Geller, EB; Kon, D; Yondorf, MZ | 1 |
| Anwar, M; Bajwa, A; Baluch, A; Chilian, W; Fields, AM; Fox, C; Hoover, JM; Huffman, S; Ibrahim, IN; Kaye, AD; Kaye, AJ | 1 |
1 review(s) available for n(g)-iminoethylornithine and morphine
| Article | Year |
|---|---|
Nitric oxide synthase inhibitors. Preclinical studies of potential use for treatment of opioid withdrawal.
Topics: Adrenergic alpha-Agonists; Animals; Arginine; Blood Pressure; Clonidine; Depression, Chemical; Enzyme Inhibitors; Heart Rate; Indazoles; Morphine; Narcotics; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Opioid-Related Disorders; Ornithine; Substance Withdrawal Syndrome | 1995 |
4 other study(ies) available for n(g)-iminoethylornithine and morphine
| Article | Year |
|---|---|
The molecular mechanism of central analgesia induced by morphine or carbachol and the L-arginine-nitric oxide-cGMP pathway.
Topics: Analgesia; Animals; Arginine; Brain; Carbachol; Cyclic GMP; Dinoprostone; Male; Molsidomine; Morphine; Nitric Oxide; Ornithine; Phthalazines; Rats; Rats, Wistar | 1992 |
The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release.
Topics: Analgesia; Animals; Arginine; Cyclic GMP; Male; Methylene Blue; Molsidomine; Morphine; Nitric Oxide; Ornithine; Phthalazines; Rats; Rats, Inbred Strains | 1991 |
Role of the nitric-oxide synthase isoforms during morphine-induced hyperthermia in rats.
Topics: Animals; Body Temperature; Drug Interactions; Enzyme Inhibitors; Fever; Guanidines; Indazoles; Infusions, Parenteral; Isoenzymes; Male; Morphine; Nitric Oxide Synthase; Ornithine; Rats; Rats, Sprague-Dawley | 2003 |
Morphine, opioids, and the feline pulmonary vascular bed.
Topics: Analgesics, Opioid; Animals; Blood Pressure; Cats; Diphenhydramine; Dose-Response Relationship, Drug; Drug Interactions; Female; Fentanyl; Glyburide; Lung; Male; Meperidine; Morphine; Naloxone; Ornithine; Piperidines; Prospective Studies; Pulmonary Artery; Pulmonary Circulation; Remifentanil; Sufentanil; Sulfonamides; Vasodilation; Vasodilator Agents | 2008 |